tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ATXS Stock Latest News

BioCryst receives early termination of HSR waiting period for Astria acquisition
The FlyBioCryst receives early termination of HSR waiting period for Astria acquisition
16d ago
ATXS
BCRX
Astria Therapeutics Reports Q3 2025 Results and BioCryst Acquisition
PremiumCompany Announcements
Astria Therapeutics Reports Q3 2025 Results and BioCryst Acquisition
1M ago
ATXS
Astria Therapeutics: Hold Rating Amid Acquisition and Financial Stability with Future Growth Prospects
PremiumRatings
Astria Therapeutics: Hold Rating Amid Acquisition and Financial Stability with Future Growth Prospects
1M ago
ATXS
Astria Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe Fly
Astria Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
1M ago
ATXS
Is ATXS a Buy, Before Earnings?
PremiumPre-Earnings
Is ATXS a Buy, Before Earnings?
1M ago
ATXS
Astria Therapeutics announces final results from ALPHA-STAR trial
PremiumThe FlyAstria Therapeutics announces final results from ALPHA-STAR trial
1M ago
ATXS
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment
Premium
Company Announcements
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment
2M ago
ATXS
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment
Premium
Company Announcements
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment
2M ago
ATXS
Astria Therapeutics’ STAR-0310 Study: A Promising Step Forward
PremiumCompany Announcements
Astria Therapeutics’ STAR-0310 Study: A Promising Step Forward
2M ago
ATXS
Astria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Astria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2M ago
ATXS
BioCryst price target raised to $26 from $24 at Cantor Fitzgerald
PremiumThe Fly
BioCryst price target raised to $26 from $24 at Cantor Fitzgerald
2M ago
ATXS
BCRX
Astria Therapeutics downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Astria Therapeutics downgraded to Neutral from Outperform at Wedbush
2M ago
ATXS
BioCryst price target raised to $27 from $17 at Citizens JMP
PremiumThe FlyBioCryst price target raised to $27 from $17 at Citizens JMP
2M ago
ATXS
BCRX
Astria downgraded to Market Perform from Outperform at Citizens JMP
Premium
The Fly
Astria downgraded to Market Perform from Outperform at Citizens JMP
2M ago
ATXS
BioCryst reinstated with a Buy at TD Cowen
Premium
The Fly
BioCryst reinstated with a Buy at TD Cowen
2M ago
ATXS
BCRX
Astria Therapeutics downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
Astria Therapeutics downgraded to Perform from Outperform at Oppenheimer
2M ago
ATXS
BioCryst weakness presents ‘compelling’ buying opportunity, says RBC
PremiumThe Fly
BioCryst weakness presents ‘compelling’ buying opportunity, says RBC
2M ago
ATXS
BCRX
Strategic Acquisition of Astria Therapeutics by BioCryst Pharmaceuticals Highlights Potential of Navenibart for HAE Prophylaxis
PremiumRatings
Strategic Acquisition of Astria Therapeutics by BioCryst Pharmaceuticals Highlights Potential of Navenibart for HAE Prophylaxis
2M ago
ATXS
BioCryst price target raised to $15 from $14 at Jefferies
PremiumThe Fly
BioCryst price target raised to $15 from $14 at Jefferies
2M ago
ATXS
BCRX
Hold Rating on BCRX Amid Strategic Acquisition of Astria Therapeutics and Market Challenges
PremiumRatingsHold Rating on BCRX Amid Strategic Acquisition of Astria Therapeutics and Market Challenges
2M ago
ATXS
Astria Therapeutics downgraded to Hold from Buy at Jefferies
Premium
The Fly
Astria Therapeutics downgraded to Hold from Buy at Jefferies
2M ago
ATXS
BCRX
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
2M ago
MU
AMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >